Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 6,359 | 0 | 0 | 0 |
| Gross Profit | N/A | 6,359 | N/A | N/A | N/A |
| Operating Expenses | 6,438 | 8,827 | 17,288 | 34,419 | 66,018 |
| Operating Income | -6,438 | -2,468 | -17,288 | -34,419 | -66,018 |
| Other Income | 443 | -675 | 234 | -1,646 | -709 |
| Pre-tax Income | -5,995 | -3,143 | -17,054 | -36,065 | -66,727 |
| Net Income Continuous | -5,995 | -3,143 | -17,054 | -36,065 | -66,727 |
| Net Income | $-5,995 | $-3,143 | $-17,054 | $-36,065 | $-66,727 |
| EPS Basic Total Ops | -0.49 | -0.84 | -6.63 | -16.65 | -38.15 |
| EPS Basic Continuous Ops | -0.49 | -0.84 | -6.63 | -16.65 | -38.15 |
| EPS Diluted Total Ops | -0.49 | -0.84 | -6.63 | -16.65 | -38.15 |
| EPS Diluted Continuous Ops | -0.49 | -0.84 | -6.63 | -16.65 | -38.15 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | N/A | -16.65 | -24.40 |
| EBITDA(a) | $-6,193 | $-1,836 | $-16,220 | $-33,183 | $-64,638 |